Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain

NCT00446797 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankle Sprain

Interventions

DRUG: Non-selective NSAIDS
DRUG: Celecoxib

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.